ClinicalTrials.Veeva

Menu

Microcirculation in Perforator Flaps. Enhancing Tissue Survival

University of Oslo (UIO) logo

University of Oslo (UIO)

Status and phase

Unknown
Early Phase 1

Conditions

Reconstructive Surgery
Microcirculation

Treatments

Drug: Indocyanine green (ICG)

Study type

Interventional

Funder types

Other

Identifiers

NCT01204554
08/223b.2008/3837 (REK)

Details and patient eligibility

About

The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.

Full description

Perforator flaps are increasingly used in reconstructive surgery both as pedicled and free flaps, mostly because of reduced donor site morbidity and superior aesthetic result. However, the there is still much to learn about the hemodynamic changes within these flaps.The aim of the present study is to assess the microcirculatory changes in the distal part of the perforator flap using ICG fluorescence angiography.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • patients submitted to elective abdominoplasty

Exclusion criteria

  • body mass index < 30 kg/m2
  • morbidly obese
  • patients with comorbidity such as diabetes
  • vascular disease
  • smokers
  • patients < 18 years, and patients using anti-coagulant therapy
  • pregnant
  • severe hepatic insufficiency were excluded and a history of allergic reactions to ICG and iodide.

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Haris Mesic, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems